Evrysdi is an oral medication containing the active ingredient risdiplam. It is used to treat spinal muscular atrophy (SMA), a rare genetic disorder that affects motor neurons and leads to muscle weakness and loss of movement.
Indications:
-
Treatment of spinal muscular atrophy (SMA) in adults and children aged 2 months and older.
-
Helps increase production of SMN protein, essential for survival of motor neurons.
Warnings & Precautions:
-
Must be used under the supervision of a specialist.
-
Contraindicated in case of allergy to risdiplam or any component of the drug.
-
Common side effects may include diarrhea, skin rash, and upper respiratory infections.
-
Regular blood tests may be required to monitor liver function and hemoglobin levels.
Storage:
-
Store in the refrigerator between 2–8°C.
-
Shake well before use.
-
Dosage is determined by the doctor based on the patient’s weight.





Reviews
There are no reviews yet.